BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 20840272)

  • 1. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
    Seale FG; Robinson RD; Neal GS
    J Reprod Med; 2000 Jun; 45(6):507-10. PubMed ID: 10900588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of insulin sensitizers in polycystic ovarian syndrome.
    Baillargeon JP
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycystic ovary syndrome (PCOS)].
    Thaler CJ
    MMW Fortschr Med; 2007 May; 149(21):33-5. PubMed ID: 17668731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Christakou CD; Kandaraki E; Economou FN
    Eur J Endocrinol; 2010 Feb; 162(2):193-212. PubMed ID: 19841045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Franks S
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
    J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.
    Khattab S; Mohsen IA; Aboul Foutouh I; Ashmawi HS; Mohsen MN; van Wely M; van der Veen F; Youssef MA
    Gynecol Endocrinol; 2011 Oct; 27(10):789-93. PubMed ID: 21247239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin in obstetric and gynecologic practice: a review.
    McCarthy EA; Walker SP; McLachlan K; Boyle J; Permezel M
    Obstet Gynecol Surv; 2004 Feb; 59(2):118-27. PubMed ID: 14752300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.
    Ghazeeri GS; Nassar AH; Younes Z; Awwad JT
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):658-78. PubMed ID: 22375613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
    Leeman L; Acharya U
    J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.